1123965

Mark S. Lee, M.D. — FEI 3004950794

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 29, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Antonio, TX (United States)

Additional Details

Clinical Investigator (CI)